Status:
COMPLETED
Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Urinary Incontinence, Stress
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The study evaluates the effectiveness of duloxetine in reducing urinary incontinence occurrences in women due to physical stress(e.g. stomach pressure on bladder). Incontinence is the inability to con...
Eligibility Criteria
Inclusion
- female outpatients \> or = 18 years of age
- experience episodes of stress urinary incontinence
- must have an educational level and degree of understanding English
- are free of urinary tract infections
- can use the toilet independently
Exclusion
- any in or outpatient surgery in the last six months
- suffer from severe constipation
- extension of any internal organs beyond vaginal opening
- currently breastfeeding
- any nervous diseases affecting normal urinary function
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00190827
Start Date
September 1 2003
End Date
May 1 2006
Last Update
January 26 2007
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559 OR 1-317-615-4559) Mon-Fri from 9am to 5pm Eastern time(UTC/GMT - 5 hours, EST) or speak with your personal physician
Rio de Janeiro, Brazil, 20551-030
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559 or 1-317-615-4559) Mon-Fri from 9am to 5pm Eastern time(UTC/GMT - 5 hours, EST) or speak with your personal physician
Québec, Quebec, Canada, Quebec G1S 2L6
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559 OR 1-317-615-4559) Mon-Fri from 9am to 5pm Eastern time(UTC/GMT - 5 hours, EST) or speak with your personal physician
Paris, France, 75651
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559 OR 1-317-615-4559) Mon-Fri from 9am to 5pm Eastern time(UTC/GMT - 5 hours, EST) or speak with your personal physician
Mainz, Germany, 55131